Estimation of Biomarkers in an Antianaemic Polyherbal Oral Liquid Formulation using HPTLC and Simultaneous Estimation of Ascorbic Acid, Gallic Acid and Resveratrol Using the RP-HPLC Method
Background: Anaemia affects over two billion people globally, and there is growing interest in natural, polyherbal remedies as safe and effective alternatives to conventional therapies. Standardisation of such formulations is essential for ensuring quality, safety, and efficacy. This study aims to develop and standardise a polyherbal oral liquid formulation with antianaemic potential and to quantify the key bioactive markers ascorbic acid, gallic acid, and resveratrol using validated High Performance Thin Layer Chromatography (HPTLC) and Reverse Phase- High Performance Liquid Chromatography (RP-HPLC) methods. Methods: Plant materials (Punica granatum, Boerhaavia diffusa, Vitis vinifera, and Terminalia belerica) were collected, authenticated, and extracted using hydroalcoholic and freeze-drying techniques. A polyherbal oral liquid formulation was developed and subjected to macroscopic, physicochemical, and phytochemical evaluations. Total phenolic content was estimated via the Folin-Ciocalteu method. Biomarkers were quantified using HPTLC and simultaneously estimated by RP-HPLC, followed by method validation for precision, linearity, accuracy, Limit of Detection (LOD), Limit of Quantification (LOQ) and robustness as per International Council on Harmonisation (ICH) guidelines. Results: The HPTLC analysis revealed the presence of ascorbic acid (0.021%), catechin (0.09%), gallic acid (0.21%), and resveratrol (0.004%). RP-HPLC quantification in the formulation showed ascorbic acid (1.12 ± 0.214 mg/g), gallic acid (2.25 ± 0.114 mg/g), and resveratrol (0.042 ± 0.314 mg/g). The analytical method showed high linearity (R² > 0.99), precision (RSD < 2%), and acceptable LOD and LOQ values. Conclusion: The developed polyherbal oral liquid formulation was successfully standardised and validated. The study confirmed the presence and quantity of key antioxidant and hematinic biomarkers, supporting its potential as a safe, natural antianaemic therapy. Major Findings: The polyherbal